About Vineet Agarwal
Vineet Agarwal is the Chief Financial Officer with extensive experience in investment banking, specializing in the biopharma sector.
Known information
Vineet Agarwal serves as the Chief Financial Officer, bringing over 14 years of investment banking expertise, particularly in the biopharma industry. He began his career at J.P. Morgan in 2007, where he ascended through various leadership positions and was most recently the Senior Executive Director of the healthcare investment banking group in New York. Agarwal has played a pivotal role in numerous mission-critical financings, including IPOs, SPACs, and convertible equity and debt deals. He has also advised on significant strategic transactions such as acquisitions, mergers, and licensing deals, contributing to transformative M&A activities in the biopharma sector. Agarwal holds an MBA from the Institute of Management Technology, India, and a bachelor’s degree in finance from Shri Ram College of Commerce, India.
About Korro Bio
Korro Bio is a biotechnology company specializing in RNA editing technologies, aiming to pioneer treatments for diseases, particularly focusing on the liver and central nervous system.